Reeder G S, Krishan I, Nobrega F T, Naessens J, Kelly M, Christianson J B, McAfee M K
N Engl J Med. 1984 Nov 1;311(18):1157-62. doi: 10.1056/NEJM198411013111805.
Percutaneous transluminal coronary angioplasty is widely considered to be an acceptable and less expensive alternative to bypass surgery in carefully selected patients. We compared expenditures related to cardiac care for 79 unselected patients undergoing coronary angioplasty with expenditures for 89 unselected patients undergoing elective coronary bypass surgery without a previous attempt at angioplasty. All the patients had single-vessel disease. The mean aggregate one-year monetary outlay was 15 per cent lower in the angioplasty group than in the bypass-surgery group. A major component of the expense of angioplasty was the treatment of restenosis in the 33 per cent of patients in this group in whom this late complication occurred. We conclude that percutaneous transluminal coronary angioplasty has potential for reducing expenditures for cardiac revascularization and that a further reduction may be obtainable when the rates of restenosis are improved.
经皮腔内冠状动脉成形术被广泛认为是在精心挑选的患者中，替代搭桥手术的一种可接受且成本较低的方法。我们比较了79例未经挑选接受冠状动脉成形术患者的心脏护理费用，与89例未经挑选、未曾尝试过成形术而接受择期冠状动脉搭桥手术患者的费用。所有患者均为单支血管病变。成形术组的平均一年总支出比搭桥手术组低15%。成形术费用的一个主要组成部分是该组33%发生这种晚期并发症的患者的再狭窄治疗费用。我们得出结论，经皮腔内冠状动脉成形术有降低心脏血运重建费用的潜力，并且当再狭窄发生率降低时，可能会进一步降低费用。
